Seller record · umbrellalabs.is

Umbrella Labs

Recorded September 2026 · Standard v1.1

Fails 3 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any of the thirteen pages read, and the stated condition of sale is laboratory research use only. 2 more criteria also fail; see the table below.

Research vendor. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A research compound seller offering peptides, SARMs, nootropics and research chemicals, among them semaglutide and four other GLP-1 analogues labeled for laboratory use. It publishes a certificate library of public files that open with no login.

Operating entity Umbrella Labs, Inc.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	umbrellalabs.is/terms-of-service
S2	Prescription gating	FAIL	umbrellalabs.is/checkout
S3	Pharmacy identification	FAIL	umbrellalabs.is/terms-of-service
S4	Compounding disclosure	PASS	umbrellalabs.is/the-nucleus
S5	Analytical documentation	PASS	umbrellalabs.is/wp-content/uploads/2025/04/2025-11-10-Umbrella-Labs-Semaglutide-10mg-Certificate-of-Analysis-COA.pdf
S6	Business address	PASS	umbrellalabs.is/contactus
S7	Price disclosure	PASS	umbrellalabs.is/shop/peptides/peptide-glps/semaglutide-peptide-powder-tablets
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any of the thirteen pages read, and the stated condition of sale is laboratory research use only.Source: umbrellalabs.is/terms-of-service.

S2FAILThe order path was walked from the semaglutide tablet page at 159.99 dollars to a guest checkout collecting billing details, and no screen asked an eligibility question.Source: umbrellalabs.is/checkout.

S3FAILNo pharmacy is named on any of the thirteen pages read, and a site-wide notice states that the seller is not a compounding pharmacy under section 503A.Source: umbrellalabs.is/terms-of-service.

S4PASSThe seller offers no compounded drug, states in a site-wide notice that it is not a compounding pharmacy, and prints that its statements are not evaluated by the Food and Drug Administration.Source: umbrellalabs.is/the-nucleus.

S5PASSA public certificate from Vanguard Laboratory of Olympia reports chromatographic purity above 99.80 percent on semaglutide lot ULP-48813 by HPLC, reachable with no login.Source: umbrellalabs.is/wp-content/uploads/2025/04/2025-11-10-Umbrella-Labs-Semaglutide-10mg-Certificate-of-Analysis-COA.pdf.

S6PASSThe contact page and the privacy policy print a street address with a suite number at 3280 East Hemisphere Loop in Tucson, Arizona.Source: umbrellalabs.is/contactus.

S7PASSThe semaglutide tablet page prints 159.99 dollars for thirty tablets at 7 mg each with no account required, and the cart carried the same figure.Source: umbrellalabs.is/shop/peptides/peptide-glps/semaglutide-peptide-powder-tablets.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, retatrutide, cagrilintide and survodutide, peptide tablets and capsules, SARMs, nootropics, research chemicals, laboratory supplies.

Sellers passing S1, prescriber requirement

Records dated August 2026

Records dated September 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.